According to the International Association of Athletics Federations (IAAF), should Caster Semenya not wish to take testosterone suppressing medication, she can still compete in international competition – but only against men.
The South African middle-distance ace recently lost a landmark case against the federations rules, which ordered that women with a disorder of sex development (DSD) suppress their testosterone levels in order to continue competing in events ranging from the 400m hurdles, to the mile race.
Following her impressive performance in the IAAF Diamond League in Doha, which was her last international event before the new rules were enforced, Semenya indicated that she was not willing to take any medication.
The ruling had also come under fire from the World Medical Association (WMA), which classified it as a breach of ethic and urged doctors not to administer such treatment.
In response to the WMA, the IAAF issued out a statement in its website, stating that should a DSD athletes – in consultation with her medical team – not wish to suppress their testosterone levels, she would not be allows to compete in the “female” classification, but is welcome to compete in an “intersex” classification that could be offered in said event.
“If she decides not to do so, she will not be entitled to compete in the female classification of any Restricted Event at an International Competition.
“However, she would still be entitled to compete in the male classification at any competition at any level, in any discipline, without restriction; in any ‘intersex’ (or similar) classification that the event organiser may offer at any competition at any level, in any discipline, without restriction.”
With the controversial rules in place, Semenya – and other DSD athletes – is only allowed to compete in races outside the Restricted Events without testosterone-suppressing medication, as well as any competition that is not an International Competition.